FDA Approved: ZYVOX — Supplemental Application (Hp Halden Pharma AS)

View source ↗

Summary

The FDA approved a supplemental application for Zyvox (linezolid) submitted by Hp Halden Pharma AS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Pneumonia
• Skin and Soft Tissue Infections
• Vancomycin-resistant Enterococcus Infection

Drugs mentioned

• ZYVOX (LINEZOLID)

Snippet

SUPPL AP for ZYVOX (LINEZOLID)